EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)



The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)



Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 17: 533-542



Since the introduction of continuous ambulatory peritoneal dialysis by Popovich et al [1] and the subsequent modification of the technique by Oreopoulos et al [2], an increasing number of patients with end-stage renal disease are maintained on this new treatment modality. To date, there has not been any report of the effect of CAPD on the evolution of renal osteodystrophy which is one of the major complications of chronic renal failure. In this report we will present the results of our radiological and biochemical studies of renal osteodystrophy in 28 patients who have been on CAPD from 6 to 23 months.

(PDF emailed within 1 workday: $29.90)

Accession: 044636916

Download citation: RISBibTeXText

PMID: 6787584



Related references

Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Peritoneal Dialysis International 13 Suppl 2: S451-S453, 1993

Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. American Journal of Medicine 82(6): 1148-1156, 1987

Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis. Advances in Experimental Medicine and Biology 151: 429-440, 1982

Hematocrit and residual renal creatinine clearance in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Peritoneal Dialysis International 10(4): 279-282, 1990

Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clinical and Experimental Nephrology 8(4): 339-343, 2004

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis. Journal of Pediatrics 103(5): 729-734, 1983

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis. Pediatric Research 18(8): 742-747, 1984

Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clinical Nephrology 27(5): 245-249, 1987

Comparison of two catheters for peritoneal access in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Scandinavian Journal of Urology and Nephrology 17(3): 343-346, 1983

Air under the diaphragm in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Peritoneal Dialysis International 9(4): 309-311, 1989

Eosinophilic peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Ugeskrift for Laeger 147(34): 2670-2672, 1985

Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis. Reumatologia (Warsaw) 34(2-3 PART 2): 705-709, 1996

Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis. Acta Paediatrica Japonica 32(1): 44-50, 1990

Renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Mineral & Electrolyte Metabolism 10(5): 326-332, 1984

Pharmacokinetics of cefepime bmy 28142 in patients undergoing continuous ambulatory peritoneal dialysis capd. Pharmacotherapy 10(3): 239, 1990